RP

Rachana Paul

Active Director Director DIN 08973201
DIN 08973201 First appointment Nov 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2020
Shareholding value •••• Premium profile

About Rachana Paul

Data last updated:

Rachana Paul is a Director at Sarv Lifesciences Private Limited (since 2020). The company operates in Pharma. Sarv Lifesciences Private Limited reported revenue of ₹46,758 (FY 2025).

DIN 08973201
Primary Designation Director
Industry Pharma
First Appointment 25 Nov 2020
Oldest Company Age 5 yrs
Largest company Sarv Lifesciences Private Limited · ₹46,758 (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sarv Lifesciences Private Limited U51909DL2020PTC373721
Director25 Nov 20202020₹46,758 (FY 2025)Active

Board colleagues of Rachana Paul

NameDINCompanyDesignation
Seema Nasa03246779Sarv Lifesciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Sarv Lifesciences Private Limited
Premium access

Shareholding and investment profile for Rachana Paul

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rachana Paul

Rachana Paul currently holds 1 directorship: Sarv Lifesciences Private Limited (Director, since 25 Nov 2020, revenue ₹46,758 (FY 2025)).

Rachana Paul was first appointed on 25 Nov 2020 as Director at Sarv Lifesciences Private Limited.

The current boards of Rachana Paul's companies include Seema Nasa (Sarv Lifesciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available